Curaleaf Holdings, Inc. income statement CURLF

In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, Curaleaf Holdings, Inc. reported revenue of $352.6 million. It recorded a net loss of $32.7 million. Operating income came to $2.9 million, an operating margin of 0.8%. Diluted earnings per share were -$0.12.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Sep 30, 2026
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Revenue
—
353
340
Cost of revenue
—
182
170
Gross profit
—
170
170
Selling, general and administrative
—
131
132
Operating income
—
3
4
Interest income
—
0
0
Foreign currency gain (loss)
—
-0
-3
Other income (expense)
—
-26
-31
Pretax income
—
-23
-26
Income tax
—
15
-39
Net income
—
-33
13
Basic EPS
—
-0.12
0.05
Diluted EPS
—
-0.12
0.05
Weighted average shares, basic
—
265
263
Weighted average shares, diluted
—
265
271
Other measures
Depreciation and amortization
—
52
49
EBITDA
—
54
53
Margins
Gross margin
—
48.34%
49.96%
Operating margin
—
0.83%
1.24%
Pretax margin
—
-6.48%
-7.74%
Profit margin
—
-9.28%
3.68%
EBITDA margin
—
15.45%
15.53%
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
CURLF (OTC)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Stamford, CT
SEC filer status
Large accelerated filer
SEC CIK
1756770

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.